Stem Cell and Regenerative Medicine

Stem Cell and Regenerative Medicine

Open Access
ISSN: 2639-9512
Research Article

SB cell® Therapy Ameliorates IL-1 RA-Deficiency-Associated Psoriasis

Authors: Tina Zhang, Lee Chen, Monica Lui, Xiao Chen, Wen Ying Lee, Jonathan Tang, Pei-Ju Chu, Tom Flashman, James Wang.

DOI: 10.33425/2639-9512.1012


Abstract

In this study, we find a subject with a deficiency of IL-1 receptor antagonist (DIRA) – like syndrome who also has symptoms similar to that of psoriasis. Within 24 hours of intravenous infusion with autologous SB cells®, the subject’s IL-1 RA expression is shown to increase drastically, during which the subject experiences relief from his psoriasis-like symptoms.

The subject was diagnosed with psoriasis as a young adult; however, no treatment has offered relief for the psoriatic plaques located along his forearms and back. Currently his diagnosis is classified as psoriasis and his management of the disease is minimal. Throughout the course of SB cell® treatments, we used ELISA to monitor a panel of cytokines, it was here we noticed the subject’s deficient IL-1RA expression without treatment, his expression levels were near 0 pg/ml. 24 Hours after treatment, measurements of his expression levels were increased several thousand fold.

This case presents the possibility that SB cells can act as a treatment for psoriasis due to IL-1 RA deficiency.

View / Download PDF
Citation: Tina Zhang, Lee Chen, Monica Lui, et al. SB cell® Therapy Ameliorates IL-1 RA-Deficiency-Associated Psoriasis. 2017; 1(2). DOI: 10.33425/2639-9512.1012
Editor-in-Chief
Henry E. Young
Henry E. Young
Chief Executive Officer and Consultant | Dragonfly Foundation for Research and Development

View full editorial board →
Journal Metrics
Impact Factor 2.5*
Acceptance Rate 80%
Time to first decision 5-10 Days
Submission to acceptance 10-15 Days